Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Laryngospasm
ADR ID BADD_A02487
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.02      Laryngeal spasm, oedema and obstruction
22.04.02.002      Laryngospasm
Description A disorder characterized by paroxysmal spasmodic muscular contraction of the vocal cords. [CTCAE] A disorder in which the adductor muscles of the VOCAL CORDS exhibit increased activity leading to laryngeal spasm. Laryngismus causes closure of the VOCAL FOLDS and airflow obstruction during inspiration. [MeSH]
MedDRA Code 10023891
MeSH ID D007826; D007826; D007826
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Glottic spasm | Laryngeal spasm | Laryngismus | Laryngospasm | Larynx muscle hypersensitive | Spasm glottis | Spasm larynx | Laryngospasms | Laryngeal Spasm | Laryngeal Spasms | Spasm, Laryngeal | Spasms, Laryngeal
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02252Tositumomab--
BADD_D02346Venlafaxine--
BADD_D02348Verapamil--
BADD_D02367Voltaren--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02473Sodium chloride0.000604%
The 7th Page    First    Pre   7    Total 7 Pages